Evidence map›Paper›PMID 33418986›Full record

ArticleSensors (Basel, Switzerland)2021

Double-Antigen Lateral Flow Immunoassay for the Detection of Anti-HIV-1 and -2 Antibodies Using Upconverting Nanoparticle Reporters.

Iida Martiskainen, Etvi Juntunen, Teppo Salminen, Karoliina Vuorenpää, Sherif Bayoumy, Tytti Vuorinen, Navin Khanna, Kim Pettersson, Gaurav Batra, Sheikh M Talha

Open access · goldAbstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Proteomics in the Diagnosis of Viral and Pathogenic Infections.Advances in experimental medicine and biology · 2026
    Review
  3. Numerical analysis of WSFrontiers in bioengineering and biotechnology · 2025
    Article
  4. Use of Lateral Flow Assays in Forensics.Sensors (Basel, Switzerland) · 2023
    Review
  5. Recent Trends in Lateral Flow Immunoassays with Optical Nanoparticles.International journal of molecular sciences · 2023
    Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Iida MartiskainenDepartment of Biotechnology, University of Turku, 20520 Turku, Finland.ORCID 0000-0001-6729-1752
Etvi JuntunenDepartment of Biotechnology, University of Turku, 20520 Turku, Finland.ORCID 0000-0003-2774-386X
Teppo SalminenDepartment of Biotechnology, University of Turku, 20520 Turku, Finland.ORCID 0000-0002-3127-4018
Karoliina VuorenpääDepartment of Biotechnology, University of Turku, 20520 Turku, Finland.ORCID 0000-0003-4290-780X
Sherif BayoumyDepartment of Biotechnology, University of Turku, 20520 Turku, Finland.
Tytti VuorinenDepartment of Virology and Clinical Microbiology, University of Turku, 20520 Turku, Finland.
Navin KhannaInternational Centre for Genetic Engineering & Biotechnology, New Delhi 110067, India.ORCID 0000-0003-1208-614X
Kim PetterssonDepartment of Biotechnology, University of Turku, 20520 Turku, Finland.
Gaurav BatraTranslational Health Science and Technology Institute, Faridabad 121001, India.
Sheikh M TalhaDepartment of Biotechnology, University of Turku, 20520 Turku, Finland.ORCID 0000-0003-1997-9530
University of Turku · FIInternational Centre for Genetic Engineering and Biotechnology · INTranslational Health Science and Technology Institute · IN

Funding

Wellcome Trust 106295/A/14/ZWellcome Trust 106295/Z/14/Z
6 · The paper itself

Abstract

Rapid diagnostic tests (RDTs) are often used for the detection of anti-human immunodeficiency virus (HIV) antibodies in remote locations in low- and middle-income countries (LMIC) with low or limited access to central laboratories. The typical format of an RDT is a lateral flow assay (LFA) with visual interpretation prone to subjectivity. This risk of misinterpretation can be overcome with luminescent upconverting nanoparticle reporters (UCNPs) measured with a miniaturized easy-to-use reader instrument. An LFA with UCNPs for anti-HIV-1/2 antibodies was developed and the assay performance was evaluated extensively with challenging patient sample panels. Sensitivity (

Indexed as

HIV-1NanoparticlesAntibodiesHumansImmunoassayImmunologic TestsSensitivity and SpecificityAntibodiesdiagnosticsHIVlateral flow assaypoint of carerapid testingupconverting nanoparticles

Identifiers

PMID33418986
PMCPMC7825344
OpenAlexW3120720278

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.